ArTS Archivio della ricerca di Trieste

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 282
Titolo Data di pubblicazione Autori File
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer 1-gen-2003 Generali, D. +
Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy 1-gen-2004 Generali, Daniele +
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function 1-gen-2005 Generali, Daniele +
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines 1-gen-2005 Generali, D. +
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes 1-gen-2005 Generali, D. +
Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: A single-institution phase III trial 1-gen-2005 Generali, D. +
Is pathologic complete response a valid surrogate parameter of treatment efficacy in HER2 positive breast cancer patients undergoing primary chemotherapy plus trastuzamab? [13] 1-gen-2005 Generali, Daniele +
Biological therapies for metastatic breast cancer: Antiangiogenesis 1-gen-2006 GENERALI, DANIELE +
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 1-gen-2006 GENERALI, DANIELE +
Management of the side-effects of intravenous bisphosphonates: Targeting the serum parathyroid hormone elevation [6] 1-gen-2006 GENERALI, DANIELE +
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer 1-gen-2006 GENERALI, DANIELE +
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?[5] 1-gen-2006 GENERALI, DANIELEBONARDI, MARIA SANTINA +
EGFR genotyping in pleural fluid specimens in NSCLC patients 1-gen-2006 GENERALI, DANIELE +
Hypoxia-inducible factor-1α expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer 1-gen-2006 GENERALI, DANIELE +
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer 1-gen-2007 GENERALI, DANIELE +
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load 1-gen-2007 GENERALI, DANIELEANGELI, ALBERTO +
EGFR mutations in exons 18-21 in sporadic breast cancer [7] 1-gen-2007 GENERALI, DANIELE +
Breast tumour angiogenesis 1-gen-2007 GENERALI, DANIELE +
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases 1-gen-2008 GENERALI, DANIELEBONARDI, MARIA SANTINA +
Presurgical systemic treatment of nonmetastatic breast cancer: Facts and open questions 1-gen-2008 GENERALI, DANIELE +
Mostrati risultati da 1 a 20 di 282
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile